Connect
MJA
MJA

    Managing Barrett's oesophagus

    Geoffrey S Hebbard and Sanjay Nandurkar
    Med J Aust 2004; 180 (8): . || doi: 10.5694/j.1326-5377.2004.tb05987.x
    Published online: 19 April 2004

    Can chemoprevention reduce the risk of progression to malignancy?

    • Geoffrey S Hebbard1
    • Sanjay Nandurkar2

    • 1 Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, VIC.
    • 2 Department of Gastroenterology, Box Hill Hospital, Box Hill, VIC.


    Correspondence: 
    Competing interests:

    G S H has acted as a consultant to AstraZeneca, Novartis and Pharmacia (Pfizer), and has received research support, sponsored travel and honoraria for speaking from AstraZeneca, Novartis and Wyeth. S N has acted in an advisory capacity to Pharmacia and has received research support, sponsored travel and honoraria for speaking from AstraZeneca and Pharmacia (Pfizer).

    Author
    remove_circle_outline Delete Author
    add_circle_outline Add Author
    Comment
    Do you have any competing interests to declare? *
    I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
    I/we agree to the Terms of use of the Medical Journal of Australia *
    Email me when people comment on this article
    Online responses are no longer available. Please refer to our instructions for authors page for more information.